Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

International Conference on Circuits, Control, Communication and Computing (I4C)

Hybrid Quantum Graph Neural Networks for Molecular Toxicity Classification

Anurag Rai, G Nithish, Dasiga Venkata Ashish Kumar, Aishwarya JA

Published Sep 1, 2026• 0 citations
Publisher

Abstract

Drug discovery depends heavily on predicting molecular toxicity early and classical ML still struggles here, because the interactions that make a molecule toxic are fundamentally quantum-mechanical. This paper builds a Hybrid Quantum Graph Neural Network (QGNN) that feeds GCN-learned molecular embeddings into a Variational Quantum Circuit (VQC). A 3-layer GCN produces graphlevel embeddings, which are angle-encoded into 4-8 qubit quantum states, and Pauli-Z expectations are concatenated with classical features before the final classifier. A quantum edge embedding is also introduced, encoding bondtype information directly into entangling gate parameters. On MoleculeNet's Tox21 (7,831 compounds, 12 endpoints) and ClinTox (1,478 compounds), 5-fold cross-validation shows the hybrid 4-qubit model with edge embedding achieves 0.762 ROC-AUC on Tox21 (+3.1% over 0.739 classical baseline), while the 8-qubit hybrid model reaches 0.741 on ClinTox (+6.3% over 0.697 baseline), both with batch size 64. Smaller batches (64) consistently outperform larger batches (256) at$3-17 \times$computational cost. Quantum edge embedding yields its largest improvement with only 15 additional parameters: +16.4% on ClinTox (batch 64). Quantum-only models achieve 83.7% parameter reduction while landing consistently just below the classical baseline. Across five folds, however, every one of these differences falls inside overlapping 95% confidence intervals$(p>0.05)$, so the gains reported here are consistent in direction but not individually significant at this sample size. Total overhead for hybrid models is 10-13% extra parameters with training time ranging from 1.2 to 54.6 seconds per epoch. External validation on the held-out BBBP benchmark (2,039 compounds), performed with the same architecture and no retuning, confirms that the gain transfers: the hybrid 4-qubit model reaches 0.702 ROC-AUC against 0.649 for the classical baseline (+8.2%), the largest relative gain across the three datasets. A mechanistic interpretability analysis attributes the edge-embedding effect to bond order reaching the model only through the entangling gates, where a learnable convex combination of perbond-type angles tunes entanglement continuously instead of pinning it at the CNOT maximum; the effect is positive on reactivity-driven toxicity endpoints and negative on passive permeability, matching the chemistry of each target.

DOI
10.1109/i4c69082.2026.11759837

Related papers

A Hybrid Quantum-Classical Machine Learning Framework for Accelerated Drug Discovery

Sriramadasu Sri Sainadh, Saigeetha S.B., Jeeru Bharath Reddy +4 more

The pharmaceutical industry faces mounting challenges in drug discovery, where exploring a chemical space exceeding 10 60 possible compounds remains computationally prohibitive. Traditional in-silico screening approaches struggle to capture the quantum mechanical interactions that determine molecular behavior. To overcome these limitations, this study introduces a hybrid quantum–classical machine learning framework that uniquely integrates molecular graph theory with quantum-enhanced learning for accelerated drug discovery. Using the QM9 benchmark dataset containing 133,885 molecules of low-to-medium structural complexity, we extract Laplacian eigenvalue spectra as topological descriptors that preserve both connectivity and electronic information. These features are jointly processed by Random Forest (RF), Support Vector Machine (SVM), and a Variational Quantum Classifier (VQC) in a weighted ensemble architecture designed for balanced generalization. The Quantum Graph Neural Network (QGNN) component achieves 97.5% accuracy, while the hybrid ensemble attains 100.0% accuracy, confirming strong predictive reliability. Although quantum training requires roughly 3.2× longer computation, it captures high-dimensional correlations that classical methods overlook. Overall, the proposed framework bridges the gap between theoretical quantum computing and practical pharmaceutical modeling, providing a scalable, physics-inspired pathway toward intelligent molecular screening and next-generation drug discovery systems.

Procedia Computer Science•Jan 1, 2026•0 citations

Variational Quantum Regression for Binding Affinity Prediction: A Hybrid Quantum-Classical Framework with Explainable Molecular Descriptors

Volkan Erol

Predicting drug-target binding affinity with limited training data remains a central challenge in computational drug discovery. We introduce a hybrid quantum-classical framework combining molecular descriptors with variational quantum circuits for interpretable binding affinity prediction. Seven physicochemical descriptors (MW, logP, TPSA, HBD/HBA, rotatable bonds, aromatic rings) were encoded into 6-qubit variational circuits using parameterized rotations and controlled-Z entanglement. Quantum kernels were extracted and used for regression on 1,200 BindingDB molecules across kinase, GPCR, and protease targets, with external validation on 300 ChEMBL compounds. Performance was compared against SVR, random forest, gradient boosting, and neural network baselines using 100-fold bootstrap validation. Variational quantum regression achieved MSE = 0.056 ± 0.009, outperforming SVR by 32% (0.082 ± 0.013), RF by 28%, and GBM by 24%. Quantum advantage was most significant in low-data regimes (n < 500), where VQR maintained R2 > 0.85 versus R2 < 0.72 for classical methods. External validation confirmed generalization (R2 = 0.83). Our Explainable Quantum Pharmacology framework revealed TPSA and logP as dominant predictive features through gradientbased sensitivity analysis, aligning with established medicinal chemistry principles. Quantum kernels provide measurable, chemically interpretable improvements for molecular property prediction in data-limited scenarios. This work demonstrates practical quantum advantage for early-stage drug discovery applications on near-term quantum hardware.

•Oct 20, 2025•1 citation

Variational Quantum Eigen Solver Based Molecular Toxicity Prediction for Drug Candidate Screening

Farooq Sunar Mahammad, E. Nandini, M. V. Subramanyam +3 more

Toxic molecular compounds can be identified early, which can lower drug development costs and avoid failures in candidate screening. However, current machine learning methods typically require the creation of handcrafted molecular descriptors and are not effective at modelling complex molecular relationships. In this study, a hybrid quantum-classical molecular toxicity prediction framework is proposed to be used for drug candidate screening, based on a Variational Quantum Eigensolver (VQE). SMILES strings are used to represent molecular structures which are processed in RDKit to produce physicochemical descriptors, and quantum chemical properties from the QM9 dataset are used to enrich the molecular representation. The reduced features are then encoded into a 12-qubit variational quantum circuit for binary toxicity classification after feature standardization and Principal Component Analysis (PCA) was performed. The trained VQE-inspired classifier is deployed via a web application built using Flask with facilities for authenticated predictions of toxicity, visualization of molecular properties, and management of prediction history. The experimental results show that it is feasible to combine molecular feature engineering with hybrid quantum learning to obtain an overall classification accuracy of 84% and a recall of 94% of the toxicclass molecules. The proposed framework gives a computational platform from end to end for quantum assisted molecular toxicity prediction and provides a foundation of future quantum assisted computer-aided drug discovery.

International Conference on Modern Sustainable Systems (CMSS)•Aug 1, 2026•0 citations

Variational Quantum Attention for Molecular Graph Learning

Yu-Cheng Lin, Yu-Chao Hsu, Tai-Yue Li +2 more

Molecular property prediction is central to computational drug discovery, where graph neural networks learn to weight neighboring atomic environments during message passing. Yet it remains unclear how variational quantum circuits alter learned attention behavior in molecular graphs. We introduce an edge-aware variational quantum attention mechanism for molecular graph learning, in which the receiving atom, neighboring atom, and connecting bond jointly determine the quantum attention state. Across five molecular property and bioactivity prediction tasks, QGAT achieves competitive performance relative to GATv2, with a consistent improvement on BBBP across all six evaluated circuit ansatzes. We further compare how the quantum and classical attention scores weight molecular structure beyond accuracy. In the Verubecestat BACE1 inhibitor series, QGAT achieves a higher Spearman correlation than GATv2 and assigns positive attributions to several structural changes consistent with reported structure-activity relationships (SARs). This case study shows that the two attention mechanisms can exhibit different prediction and attribution behavior across structurally related BACE1 analogues, while broader validation is required to determine how consistently these differences generalize across chemical series and targets. Circuit ablations further show that performance depends on the circuit design. Together, these results show that variational quantum attention can serve as a viable alternative molecular attention parameterization while inducing circuit- and chemistry-dependent behavior distinct from a matched classical scorer.

quant-pharXiv:2610.04588•Oct 6, 2026•0 citations

Quantum drug discovery: a hybrid quantum graph neural network–variational quantum eigensolver framework for serine neutralization

Javier Villalba-Díez

Abstract Quantum computing has emerged as a powerful tool for modeling molecular systems with high accuracy, accelerating the search for novel therapeutic targets. In this study, we present a two-stage hybrid workflow that combines a Quantum Graph Neural Network with a Variational Quantum Eigensolver to identify potent serine neutralizers in the QM9 dataset. In the first stage, an advanced quantum graph neural network architecture incorporating attention layers, self-distillation, and an adaptive learning-rate schedule is trained to predict ionization potentials and binding free energies. Across five independent random-seed trials, our adaptive-thresholded QGNN–VQE pipeline achieves an average $$R^2$$ R 2 of $$0.990 \pm 0.008$$ 0.990 ± 0.008 and a mean absolute error of $$0.034 \pm 0.001$$ 0.034 ± 0.001 eV ( $$\approx 0.79 \pm 0.03$$ ≈ 0.79 ± 0.03 kcal/mol) on the QM9 validation set, demonstrating robust, chemical-accuracy-level predictions. Building on these high-precision predictions, the second stage employs a QAOA-inspired hybrid ranking scheme that merges quantum graph neural network outputs, feature-space similarity (via and cosine similarity), and variational quantum eigensolver-derived energy stability. This $$\alpha $$ α -weighted ( $$\alpha = 0.95$$ α = 0.95 ) scoring framework is applied to over 133,000 molecules, efficiently parsed in parallel. The final ranked list is validated through an improved bijection test, featuring an adaptive similarity threshold to ensure both structural and functional robustness. The top-scoring candidate identified by our pipeline is 5,6,7-tetrahydro-4 H-pyrazolo[4,3-c]pyridin-4-one, highlighting the efficacy of quantum-enhanced modeling in pinpointing complex pharmacological targets. These findings underscore the transformative potential of hybrid quantum-classical workflows in drug discovery, offering a flexible blueprint for advanced screening of other critical biomolecular interactions in the rapidly expanding field of quantum biology. GraphicAbstract VQE for Serine Neutralization

The European Physical Journal D•Jul 1, 2025•8 citations

Hybrid Quantum or Purely Classical? Assessing the Utility of Quantum Feature Embeddings

J. Simon Richard

Background As graph datasets—including social networks, supply chains, and bioinformatics data—grow in size and complexity, researchers are driven to search for solutions enhancing model efficiency and speed. One avenue that may provide a solution is Quantum Graph Learning (QGL), a subfield of Quantum Machine Learning (QML) that applies machine learning inspired or powered by quantum computing to graph learning tasks. Methods We reevaluate Quantum Feature Embeddings (QFE), a QGL methodology published by Xu et al. earlier this year. QFE uses Variational Quantum Circuits to preprocess node features and then sends them to a classical Graph Neural Network (GNN), with the goal of increasing performance and/or decreasing total model size. Xu et al. evaluated this methodology by comparing its performance with the performance of variously-sized classical models on the benchmark datasets PROTEINS and ENZYMES, and they report success. Our core methodology and learning task remain unchanged. However, we have made several changes to the experimental design that enhance the rigor of the study: 1) we include the testing of models with no embedder; 2) we conduct a thorough hyperparameter search using a state-of-the-art optimization algorithm; and 3) we conduct stratified five-fold cross-validation, which mitigates the bias produced by our small datasets and provides multiple test statistics from which we can calculate a confidence interval. Results We produce classical models that perform comparably to QFE and significantly outperform the small classical models used in Xu et al.’s comparison. Notably, many of our classical models achieve this using fewer parameters than the QFE models we trained. Xu et al. do not report their total model sizes. Conclusion Our study sheds doubt on the efficacy of QFE by demonstrating that small, well-tuned classical models can perform just as well as QFE, highlighting the importance of hyperparameter tuning and rigorous experimental design.

F1000Research•Aug 23, 2024•0 citations
Drug discovery depends heavily on predicting molecular toxicity early and classical ML still struggles here, because the interactions that make a molecule toxic are fundamentally quantum-mechanical. This paper builds a Hybrid Quantum Graph Neural Network (QGNN) that feeds GCN-learned molecular embeddings into a Variational Quantum Circuit (VQC). A 3-layer GCN produces graphlevel embeddings, which are angle-encoded into 4-8 qubit quantum states, and Pauli-Z expectations are concatenated with classical features before the final classifier. A quantum edge embedding is also introduced, encoding bondtype information directly into entangling gate parameters. On MoleculeNet's Tox21 (7,831 compounds, 12 endpoints) and ClinTox (1,478 compounds), 5-fold cross-validation shows the hybrid 4-qubit model with edge embedding achieves 0.762 ROC-AUC on Tox21 (+3.1% over 0.739 classical baseline), while the 8-qubit hybrid model reaches 0.741 on ClinTox (+6.3% over 0.697 baseline), both with batch size 64. Smaller batches (64) consistently outperform larger batches (256) at3−17×3-17 \times3−17×computational cost. Quantum edge embedding yields its largest improvement with only 15 additional parameters: +16.4% on ClinTox (batch 64). Quantum-only models achieve 83.7% parameter reduction while landing consistently just below the classical baseline. Across five folds, however, every one of these differences falls inside overlapping 95% confidence intervals(p>0.05)(p>0.05)(p>0.05), so the gains reported here are consistent in direction but not individually significant at this sample size. Total overhead for hybrid models is 10-13% extra parameters with training time ranging from 1.2 to 54.6 seconds per epoch. External validation on the held-out BBBP benchmark (2,039 compounds), performed with the same architecture and no retuning, confirms that the gain transfers: the hybrid 4-qubit model reaches 0.702 ROC-AUC against 0.649 for the classical baseline (+8.2%), the largest relative gain across the three datasets. A mechanistic interpretability analysis attributes the edge-embedding effect to bond order reaching the model only through the entangling gates, where a learnable convex combination of perbond-type angles tunes entanglement continuously instead of pinning it at the CNOT maximum; the effect is positive on reactivity-driven toxicity endpoints and negative on passive permeability, matching the chemistry of each target.
The pharmaceutical industry faces mounting challenges in drug discovery, where exploring a chemical space exceeding 10 60 possible compounds remains computationally prohibitive. Traditional in-silico screening approaches struggle to capture the quantum mechanical interactions that determine molecular behavior. To overcome these limitations, this study introduces a hybrid quantum–classical machine learning framework that uniquely integrates molecular graph theory with quantum-enhanced learning for accelerated drug discovery. Using the QM9 benchmark dataset containing 133,885 molecules of low-to-medium structural complexity, we extract Laplacian eigenvalue spectra as topological descriptors that preserve both connectivity and electronic information. These features are jointly processed by Random Forest (RF), Support Vector Machine (SVM), and a Variational Quantum Classifier (VQC) in a weighted ensemble architecture designed for balanced generalization. The Quantum Graph Neural Network (QGNN) component achieves 97.5% accuracy, while the hybrid ensemble attains 100.0% accuracy, confirming strong predictive reliability. Although quantum training requires roughly 3.2× longer computation, it captures high-dimensional correlations that classical methods overlook. Overall, the proposed framework bridges the gap between theoretical quantum computing and practical pharmaceutical modeling, providing a scalable, physics-inspired pathway toward intelligent molecular screening and next-generation drug discovery systems.
Predicting drug-target binding affinity with limited training data remains a central challenge in computational drug discovery. We introduce a hybrid quantum-classical framework combining molecular descriptors with variational quantum circuits for interpretable binding affinity prediction. Seven physicochemical descriptors (MW, logP, TPSA, HBD/HBA, rotatable bonds, aromatic rings) were encoded into 6-qubit variational circuits using parameterized rotations and controlled-Z entanglement. Quantum kernels were extracted and used for regression on 1,200 BindingDB molecules across kinase, GPCR, and protease targets, with external validation on 300 ChEMBL compounds. Performance was compared against SVR, random forest, gradient boosting, and neural network baselines using 100-fold bootstrap validation. Variational quantum regression achieved MSE = 0.056 ± 0.009, outperforming SVR by 32% (0.082 ± 0.013), RF by 28%, and GBM by 24%. Quantum advantage was most significant in low-data regimes (n < 500), where VQR maintained R2 > 0.85 versus R2 < 0.72 for classical methods. External validation confirmed generalization (R2 = 0.83). Our Explainable Quantum Pharmacology framework revealed TPSA and logP as dominant predictive features through gradientbased sensitivity analysis, aligning with established medicinal chemistry principles. Quantum kernels provide measurable, chemically interpretable improvements for molecular property prediction in data-limited scenarios. This work demonstrates practical quantum advantage for early-stage drug discovery applications on near-term quantum hardware.
Toxic molecular compounds can be identified early, which can lower drug development costs and avoid failures in candidate screening. However, current machine learning methods typically require the creation of handcrafted molecular descriptors and are not effective at modelling complex molecular relationships. In this study, a hybrid quantum-classical molecular toxicity prediction framework is proposed to be used for drug candidate screening, based on a Variational Quantum Eigensolver (VQE). SMILES strings are used to represent molecular structures which are processed in RDKit to produce physicochemical descriptors, and quantum chemical properties from the QM9 dataset are used to enrich the molecular representation. The reduced features are then encoded into a 12-qubit variational quantum circuit for binary toxicity classification after feature standardization and Principal Component Analysis (PCA) was performed. The trained VQE-inspired classifier is deployed via a web application built using Flask with facilities for authenticated predictions of toxicity, visualization of molecular properties, and management of prediction history. The experimental results show that it is feasible to combine molecular feature engineering with hybrid quantum learning to obtain an overall classification accuracy of 84% and a recall of 94% of the toxicclass molecules. The proposed framework gives a computational platform from end to end for quantum assisted molecular toxicity prediction and provides a foundation of future quantum assisted computer-aided drug discovery.
Molecular property prediction is central to computational drug discovery, where graph neural networks learn to weight neighboring atomic environments during message passing. Yet it remains unclear how variational quantum circuits alter learned attention behavior in molecular graphs. We introduce an edge-aware variational quantum attention mechanism for molecular graph learning, in which the receiving atom, neighboring atom, and connecting bond jointly determine the quantum attention state. Across five molecular property and bioactivity prediction tasks, QGAT achieves competitive performance relative to GATv2, with a consistent improvement on BBBP across all six evaluated circuit ansatzes. We further compare how the quantum and classical attention scores weight molecular structure beyond accuracy. In the Verubecestat BACE1 inhibitor series, QGAT achieves a higher Spearman correlation than GATv2 and assigns positive attributions to several structural changes consistent with reported structure-activity relationships (SARs). This case study shows that the two attention mechanisms can exhibit different prediction and attribution behavior across structurally related BACE1 analogues, while broader validation is required to determine how consistently these differences generalize across chemical series and targets. Circuit ablations further show that performance depends on the circuit design. Together, these results show that variational quantum attention can serve as a viable alternative molecular attention parameterization while inducing circuit- and chemistry-dependent behavior distinct from a matched classical scorer.
Abstract Quantum computing has emerged as a powerful tool for modeling molecular systems with high accuracy, accelerating the search for novel therapeutic targets. In this study, we present a two-stage hybrid workflow that combines a Quantum Graph Neural Network with a Variational Quantum Eigensolver to identify potent serine neutralizers in the QM9 dataset. In the first stage, an advanced quantum graph neural network architecture incorporating attention layers, self-distillation, and an adaptive learning-rate schedule is trained to predict ionization potentials and binding free energies. Across five independent random-seed trials, our adaptive-thresholded QGNN–VQE pipeline achieves an average R2R^2R2 R 2 of 0.990±0.0080.990 \pm 0.0080.990±0.008 0.990 ± 0.008 and a mean absolute error of 0.034±0.0010.034 \pm 0.0010.034±0.001 0.034 ± 0.001 eV ( ≈0.79±0.03\approx 0.79 \pm 0.03≈0.79±0.03 ≈ 0.79 ± 0.03 kcal/mol) on the QM9 validation set, demonstrating robust, chemical-accuracy-level predictions. Building on these high-precision predictions, the second stage employs a QAOA-inspired hybrid ranking scheme that merges quantum graph neural network outputs, feature-space similarity (via and cosine similarity), and variational quantum eigensolver-derived energy stability. This α\alpha α α -weighted ( α=0.95\alpha = 0.95α=0.95 α = 0.95 ) scoring framework is applied to over 133,000 molecules, efficiently parsed in parallel. The final ranked list is validated through an improved bijection test, featuring an adaptive similarity threshold to ensure both structural and functional robustness. The top-scoring candidate identified by our pipeline is 5,6,7-tetrahydro-4 H-pyrazolo[4,3-c]pyridin-4-one, highlighting the efficacy of quantum-enhanced modeling in pinpointing complex pharmacological targets. These findings underscore the transformative potential of hybrid quantum-classical workflows in drug discovery, offering a flexible blueprint for advanced screening of other critical biomolecular interactions in the rapidly expanding field of quantum biology. GraphicAbstract VQE for Serine Neutralization
Background As graph datasets—including social networks, supply chains, and bioinformatics data—grow in size and complexity, researchers are driven to search for solutions enhancing model efficiency and speed. One avenue that may provide a solution is Quantum Graph Learning (QGL), a subfield of Quantum Machine Learning (QML) that applies machine learning inspired or powered by quantum computing to graph learning tasks. Methods We reevaluate Quantum Feature Embeddings (QFE), a QGL methodology published by Xu et al. earlier this year. QFE uses Variational Quantum Circuits to preprocess node features and then sends them to a classical Graph Neural Network (GNN), with the goal of increasing performance and/or decreasing total model size. Xu et al. evaluated this methodology by comparing its performance with the performance of variously-sized classical models on the benchmark datasets PROTEINS and ENZYMES, and they report success. Our core methodology and learning task remain unchanged. However, we have made several changes to the experimental design that enhance the rigor of the study: 1) we include the testing of models with no embedder; 2) we conduct a thorough hyperparameter search using a state-of-the-art optimization algorithm; and 3) we conduct stratified five-fold cross-validation, which mitigates the bias produced by our small datasets and provides multiple test statistics from which we can calculate a confidence interval. Results We produce classical models that perform comparably to QFE and significantly outperform the small classical models used in Xu et al.’s comparison. Notably, many of our classical models achieve this using fewer parameters than the QFE models we trained. Xu et al. do not report their total model sizes. Conclusion Our study sheds doubt on the efficacy of QFE by demonstrating that small, well-tuned classical models can perform just as well as QFE, highlighting the importance of hyperparameter tuning and rigorous experimental design.